언어 선택

GLP1R

GLP1R 분자 정보

영어 이름	Glucagon-like peptide-1	시판 약물 수	0
임상 약물 수	13	표적 별명	GLP-1
최고 연구 개발 단계	Phase 3 Clinical

영어 이름	Glucagon-like peptide-1
표적 별명	GLP-1
시판 약물 수	0
임상 약물 수	13
최고 연구 개발 단계	Phase 3 Clinical

GLP1R 제품 목록

속성
Protein (6)Cell (5)
제품 라이브러리
온라인 (11)
종
Human (11)
태그
His Tag (1)His Tag & Avi Tag (1)Fc Tag (1)- (6)His Tag & Flag Tag (1)His Tag & Avi Tag & Flag Tag (1)
마커
Unconjugated (4)Biotin-labeled (2)- (5)

제품 번호	종	발현 시스템	제품 설명
HOT CHEK-ATF096	Human	HEK293	Human GLP-1R (Luc) HEK293 Reporter Cell
HOT CHEK-ATP160	Human	HEK293	HEK293/Human GLP-1R Stable Cell Line (High Expression)
HOT GLR-H5253	Human	HEK293	Human GLP1R Protein, Fc Tag, low endotoxin (MALS verified)
HOT GLR-H82E3	Human	HEK293	Biotinylated Human GLP1R Protein, His,Avitag™ (HPLC verified)
CHEK-ATF251	Human	HEK293	Human GLP-1R (GFP) HEK293 Reporter Cell
CHEK-ATP161	Human	HEK293	HEK293/Human GLP-1R Stable Cell Line (Medium Expression)
CHEK-ATP162	Human	HEK293	HEK293/Human GLP-1R Stable Cell Line (Low Expression)
GLR-H52D4	Human	HEK293	Human GLP1R Full Length Protein (L260F), Flag,His Tag (Detergent)
GLR-H52H7	Human	HEK293	Human GLP1R Protein, His Tag, low Endotoxin (MALS verified)
GLR-H52P3	Human	HEK293	Human GLP1R Full Length Protein (VLP)

총 수량11

GLP1R분자 배경

G-protein coupled receptor for glucagon-like peptide 1 (GLP-1). Ligand binding triggers activation of a signaling cascade that leads to the activation of adenylyl cyclase and increased intracellular cAMP levels. Plays a role in regulating insulin secretion in response to GLP-1

GLP1R분자 별명

GLP-1-R, GLP-1R, glucagon like peptide 1 receptor

임상 약물 정보

영어 이름	연구 코드	연구 개발 단계	회사	적응증	임상 시험
BioGlutide	NA-931	Phase 3 Clinical	Biomed Industries Inc	Body Weight; Body Weight Changes; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight; Weight Loss	상세
Bionetide	NA-921	Phase 3 Clinical	Biomed Industries Inc	Fragile X Syndrome; Rett Syndrome	상세
ZT-006	ZT-006; ZT006	Phase 2 Clinical	Beijing QL Biopharmaceutical Co Ltd	Alzheimer Disease; Body Weight; Diabetes Mellitus; Diabetes Mellitus, Type 2; Obesity; Overweight	상세
HM-15275	HM15275; HM-15275	Phase 2 Clinical	Hanmi Pharmaceutical Co Ltd	Obesity	상세
SYH-2082	SYH-2082; SYH2082	Phase 1 Clinical	Beijing Kangchuanglian Biopharmaceutical Technology Research Co Ltd	Obesity; Overweight	상세
SNA-003	SNA003; SNA-003	Phase 1 Clinical	SN BioScience	Diabetes Mellitus; Obesity	상세
CA-111	CA-111; CA111	Phase 1 Clinical	Chongqing Chenan Biopharmaceutical Co Ltd	Body Weight	상세
ACT-300	ACT300; ACT-300	Phase 1 Clinical	Xiamen Amoytop Biotech Co Ltd	Digestive System Diseases; Metabolic Dysfunction-Associated Steatotic Liver Disease	상세
KAI-4729	HRS-4729; KAI-4729	Phase 1 Clinical	Jiangsu Hengrui Medicine Co Ltd	Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity; Overweight	상세
ZT-003	ZT003; ZT-003	Phase 1 Clinical	Beijing QL Biopharmaceutical Co Ltd	Diabetes Mellitus; Metabolic Dysfunction-Associated Steatotic Liver Disease; Obesity	상세
ANY-002	ANY-002; ANY002	Phase 1 Clinical	Anya Biopharm Inc		상세
KN-069	KN069; KN-069	Phase 1 Clinical	Suzhou Alphamab Co Ltd	Metabolic Diseases; Obesity; Overweight	상세
semaglutide (Lexaria Bioscience)		Clinical	Lexaria Bioscience Corp	Diabetes Mellitus	상세